Literature DB >> 18644884

Campylobacter-induced interleukin-8 secretion in polarized human intestinal epithelial cells requires Campylobacter-secreted cytolethal distending toxin- and Toll-like receptor-mediated activation of NF-kappaB.

Jie Zheng1, Jianghong Meng, Shaohua Zhao, Ruby Singh, Wenxia Song.   

Abstract

Campylobacter jejuni and Campylobacter coli colonize and infect the intestinal epithelium and cause acute inflammatory diarrhea. The intestinal epithelium serves as a physical barrier to, and a sensor of, bacterial infection by secreting proinflammatory cytokines. This study examined the mechanisms for Campylobacter-induced secretion of the proinflammatory chemokine interleukin-8 (IL-8) by using polarized T84 human colonic epithelial cells as a model. C. jejuni increased the secretion of both IL-8 and tumor necrosis factor alpha (TNF-alpha) in polarized epithelial cells. However, the increase in IL-8 secretion was independent of Campylobacter-stimulated TNF-alpha secretion. Polarized T84 cells secreted IL-8 predominantly to the basolateral medium independently of the inoculation direction. While there was a significant correlation between the levels of IL-8 secretion and Campylobacter invasion, all 11 strains tested increased IL-8 secretion by polarized T84 cells despite their differences in adherence, invasion, and transcytosis efficiencies. Cell-free supernatants of Campylobacter-T84-cell culture increased IL-8 secretion to levels similar to those induced by live bacterial inoculation. The ability of the supernatant to induce IL-8 secretion was reduced by flagellum and cytolethal distending toxin (CDT) gene mutants, treatment of the supernatant with protease K or heat, or treatment of T84 cells with the Toll-like receptor (TLR) inhibitor MyD88 inhibitory peptide or chloroquine. NF-kappaB inhibitors or cdtB mutation plus MyD88 inhibitor, but not flaA cdtB double mutations, abolished the ability of the supernatant to induce IL-8 secretion. Taken together, our results demonstrate that Campylobacter-induced IL-8 secretion requires functional flagella and CDT and depends on the activation of NF-kappaB through TLR signaling and CDT in human intestinal epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18644884      PMCID: PMC2546826          DOI: 10.1128/IAI.01317-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  59 in total

1.  NF-kappa B is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinvasive bacteria.

Authors:  D Elewaut; J A DiDonato; J M Kim; F Truong; L Eckmann; M F Kagnoff
Journal:  J Immunol       Date:  1999-08-01       Impact factor: 5.422

Review 2.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

Review 3.  Toll-like receptor-5 and the innate immune response to bacterial flagellin.

Authors:  K D Smith; A Ozinsky
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

Review 4.  TLR signaling in the gut in health and disease.

Authors:  Maria T Abreu; Masayuki Fukata; Moshe Arditi
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

5.  Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2.

Authors:  R Schwandner; R Dziarski; H Wesche; M Rothe; C J Kirschning
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

6.  Fibronectin-facilitated invasion of T84 eukaryotic cells by Campylobacter jejuni occurs preferentially at the basolateral cell surface.

Authors:  Marshall R Monteville; Michael E Konkel
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF-{kappa}B.

Authors:  Maria Loiarro; Claudio Sette; Grazia Gallo; Andrea Ciacci; Nicola Fantò; Domenico Mastroianni; Paolo Carminati; Vito Ruggiero
Journal:  J Biol Chem       Date:  2005-03-08       Impact factor: 5.157

8.  Discovery of quinazolines as a novel structural class of potent inhibitors of NF-kappa B activation.

Authors:  Masanori Tobe; Yoshiaki Isobe; Hideyuki Tomizawa; Takahiro Nagasaki; Hirotada Takahashi; Tominaga Fukazawa; Hideya Hayashi
Journal:  Bioorg Med Chem       Date:  2003-02-06       Impact factor: 3.641

9.  Activation of the transcription factor NF-kappaB by Campylobacter jejuni.

Authors:  Kenneth H Mellits; Joseph Mullen; Matthew Wand; Gisèle Armbruster; Amit Patel; Phillippa L Connerton; Maeve Skelly; Ian F Connerton
Journal:  Microbiology (Reading)       Date:  2002-09       Impact factor: 2.777

View more
  52 in total

1.  Curcumin regulates airway epithelial cell cytokine responses to the pollutant cadmium.

Authors:  Jessica Rennolds; Smitha Malireddy; Fatemat Hassan; Susheela Tridandapani; Narasimham Parinandi; Prosper N Boyaka; Estelle Cormet-Boyaka
Journal:  Biochem Biophys Res Commun       Date:  2011-11-28       Impact factor: 3.575

2.  Campylobacter jejuni translocation across intestinal epithelial cells is facilitated by ganglioside-like lipooligosaccharide structures.

Authors:  Rogier Louwen; Edward E S Nieuwenhuis; Leonie van Marrewijk; Deborah Horst-Kreft; Lilian de Ruiter; Astrid P Heikema; Willem J B van Wamel; Jaap A Wagenaar; Hubert P Endtz; Janneke Samsom; Peter van Baarlen; Anna Akhmanova; Alex van Belkum
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

Review 3.  Campylobacter jejuni and associated immune mechanisms: short-term effects and long-term implications for infants in low-income countries.

Authors:  Amanda E Schnee; William A Petri
Journal:  Curr Opin Infect Dis       Date:  2017-06       Impact factor: 4.915

4.  Cholesterol depletion reduces entry of Campylobacter jejuni cytolethal distending toxin and attenuates intoxication of host cells.

Authors:  Chia-Der Lin; Cheng-Kuo Lai; Yu-Hsin Lin; Jer-Tsong Hsieh; Yu-Ting Sing; Yun-Chieh Chang; Kai-Chuan Chen; Wen-Ching Wang; Hong-Lin Su; Chih-Ho Lai
Journal:  Infect Immun       Date:  2011-07-05       Impact factor: 3.441

5.  Cystic Fibrosis Transmembrane Conductance Regulator Reduces Microtubule-Dependent Campylobacter jejuni Invasion.

Authors:  Junko Kido; Takaaki Shimohata; Sachie Amano; Sho Hatayama; Anh Quoc Nguyen; Yuri Sato; Yuna Kanda; Aya Tentaku; Shiho Fukushima; Mutsumi Nakahashi; Takashi Uebanso; Kazuaki Mawatari; Akira Takahashi
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

6.  Reduced intestinal epithelial mitochondrial function enhances in vitro interleukin-8 production in response to commensal Escherichia coli.

Authors:  Alpana Saxena; Fernando Lopes; Derek M McKay
Journal:  Inflamm Res       Date:  2018-07-20       Impact factor: 4.575

7.  Diarrheal Mechanisms and the Role of Intestinal Barrier Dysfunction in Campylobacter Infections.

Authors:  Fábia Daniela Lobo de Sá; Jörg-Dieter Schulzke; Roland Bücker
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

8.  TLR4 and TLR21 expression, MIF, IFN-β, MD-2, CD14 activation, and sIgA production in chickens administered with EFAL41 strain challenged with Campylobacter jejuni.

Authors:  Karaffová V; Marcinková E; Bobíková K; Herich R; Revajová V; Stašová D; Kavuľová A; Levkutová M; Levkut M; Lauková A; Ševčíková Z; Levkut M
Journal:  Folia Microbiol (Praha)       Date:  2016-10-03       Impact factor: 2.099

Review 9.  Inflammation and colorectal cancer, when microbiota-host mutualism breaks.

Authors:  Marco Candela; Silvia Turroni; Elena Biagi; Franck Carbonero; Simone Rampelli; Carla Fiorentini; Patrizia Brigidi
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

10.  Campylobacter jejuni outer membrane vesicles play an important role in bacterial interactions with human intestinal epithelial cells.

Authors:  Abdi Elmi; Eleanor Watson; Pamela Sandu; Ozan Gundogdu; Dominic C Mills; Neil F Inglis; Erin Manson; Lisa Imrie; Mona Bajaj-Elliott; Brendan W Wren; David G E Smith; Nick Dorrell
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.